Login / Signup
Case Study Cites Immune Reaction to High Adeno-Associated Virus Dose in Explaining Duchenne Muscular Dystrophy Trial Death.
Alex Philippidis
Published in:
Human gene therapy (2023)
Keyphrases
</>
duchenne muscular dystrophy
study protocol
phase iii
clinical trial
phase ii
muscular dystrophy
gene therapy
randomized controlled trial
open label
double blind